Brief: Heat Biologics Inc Says On Jan 31, Co, Elusys Therapeutics Irrevocably Waived Until Feb. 28, 2022 Their Right To Terminate Deal, Plan Of Merger And Reorganization
03/02/2022 21:55
Feb 3 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS INC - ON JAN 31, CO, ELUSYS THERAPEUTICS
IRREVOCABLY WAIVED UNTIL FEB. 28, 2022 THEIR RIGHT TO TERMINATE
DEAL, PLAN OF MERGER AND REORGANIZATION
Source: [ID: https://bit.ly/3sf25LD]
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company